EMA released for comment the attached draft guideline on "Guideline on the quality aspects of mRNA vaccines". The deadline for response is 30Sep25, so there is some time for AAPS to form a team and generate a response.
Please review the draft guideline and respond to me ([email protected]) by Thursday, 10 April 25, if you feel AAPS should make a comment and if you are willing to serve on the Response Team for this Guideline.
Thank you for your consideration.
------------------------------
Joan Korth-Bradley Pharm.D., Ph.D., FAAPS
Clinical Pharmacologist
Vivpro
Lower Gwynedd PA
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------